Monte Rosa Therapeutics, Inc. (GLUE)
17.31
+0.08
(+0.46%)
USD |
NASDAQ |
Dec 11, 11:56
Monte Rosa Therapeutics Price: 17.31 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 133.23 |
| AVITA Medical, Inc. | 3.54 |
| NanoVibronix, Inc. | 4.18 |
| Mirum Pharmaceuticals, Inc. | 64.65 |
| Day One Biopharmaceuticals, Inc. | 8.61 |
Price Related Metrics
| PE Ratio | 56.68 |
| PS Ratio | 7.367 |
| Price to Book Value | 4.585 |
| Price to Free Cash Flow | 9.222 |
| Earnings Yield | 1.76% |
| Market Cap | 1.127B |
| Operating PE Ratio | 157.14 |
| Normalized PE Ratio | 56.68 |